Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-31

Clinical Trial Update: ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on PROs and caregiver burden in children with atopic dermatitis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Rochester | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2022-10-31